Stay updated on Aurinia Pharmaceuticals Press Releases

Sign up to get notified when there's something new on the Aurinia Pharmaceuticals Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Aurinia Pharmaceuticals Press Releases page

  1. Check
    yesterday
    Change Detected
    Summary
    A new press release announcing Aurinia's financial results for the three and nine months ended September 30, 2025, and an update on recent business progress was added (dated November 3, 2025 and November 4, 2025). Two older press releases—one about participating in a conference and another about the AUR200 trial dosing—were removed.
    Difference
    3%
    Check dated 2025-11-10T03:41:12.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Replace a past financial results item with a forward-looking press update about upcoming data presentations for LUPKYNIS at major conferences.
    Difference
    8%
    Check dated 2025-10-19T16:23:55.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Update: new content highlights including growth, AUR200, Japan approval, and real-world data; older versioned headlines removed.
    Difference
    41%
    Check dated 2025-10-12T14:19:14.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    Updated corporate update: removes the Q2 results release notice from 2024 and adds a 2025 response post, signaling a shift in published company communications.
    Difference
    5%
    Check dated 2025-10-05T09:35:01.000Z thumbnail image
  7. Check
    101 days ago
    Change Detected
    Summary
    Aurinia Pharmaceuticals has updated its financial reporting date to July 31, 2025, while removing a previous announcement regarding participation in investor healthcare conferences scheduled for July 2, 2024.
    Difference
    6%
    Check dated 2025-08-01T19:27:28.000Z thumbnail image
  8. Check
    108 days ago
    Change Detected
    Summary
    Aurinia Pharmaceuticals has announced the release date for its second quarter 2025 financial and operational results, scheduled for July 31, 2025, while the previous announcement regarding the 2024 Annual General Meeting results has been removed.
    Difference
    6%
    Check dated 2025-07-25T14:54:53.000Z thumbnail image

Stay in the know with updates to Aurinia Pharmaceuticals Press Releases

Enter your email address, and we'll notify you when there's something new on the Aurinia Pharmaceuticals Press Releases page.